0001628280-24-011026.txt : 20240313
0001628280-24-011026.hdr.sgml : 20240313
20240313183747
ACCESSION NUMBER: 0001628280-24-011026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240308
FILED AS OF DATE: 20240313
DATE AS OF CHANGE: 20240313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DuRoss Amy
CENTRAL INDEX KEY: 0001854968
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 24747362
MAIL ADDRESS:
STREET 1: 8410 GOLDEN BEAR PLACE
CITY: WHISTLER
STATE: A1
ZIP: V8E 1J7
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
wk-form4_1710369455.xml
FORM 4
X0508
4
2024-03-08
0
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001854968
DuRoss Amy
3303 MONTE VILLA PARKWAY
SUITE 310
BOTHELL
WA
98021
1
0
0
0
0
Common Stock
2024-03-08
4
A
0
11264
A
40643
D
Common Stock
2024-03-12
4
S
0
6135
16.86
D
34508
D
Common Stock
2024-03-13
4
S
0
5065
17
D
29443
D
The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the "2023 Plan") and fully vests on the first anniversary of the grant date.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.60 to $17.11, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Amy DuRoss
2024-03-13